This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,504.81 firm fixed-price delivery order contract is for the supply of 4,566,626 units of the medication Ondansetron HCL 8 mg tablets.
The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a comprehensive vehicle for providing pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order has a period of performance through December 6, 2024 and was awarded on December 5, 2024.
The contract does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor, Amerisourcebergen has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, through its extensive supply chain and distribution capabilities.
Generated 3/6/25, 10:04 AM